戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 itogenic alphavirus that causes debilitating musculoskeletal disease.
2 achment protein using a mouse model of CHIKV musculoskeletal disease.
3 welfare and quality of life of patients with musculoskeletal disease.
4 ikungunya virus cause worldwide outbreaks of musculoskeletal disease.
5 a clinician experienced in the assessment of musculoskeletal disease.
6 s that causes epidemics of acute and chronic musculoskeletal disease.
7              It is also used in the study of musculoskeletal disease.
8 avirus that causes epidemics of debilitating musculoskeletal disease.
9 be effectively targeted for the treatment of musculoskeletal diseases.
10 the longer term effects of the use of PRP in musculoskeletal diseases.
11 ate for targeted gene therapy of cardiac and musculoskeletal diseases.
12 ands, is poorly understood in the context of musculoskeletal diseases.
13 e of this allele in susceptibility to common musculoskeletal diseases.
14 , connective tissue disease, myopathies, and musculoskeletal diseases.
15 eful in cell-based therapeutic approaches to musculoskeletal diseases.
16  disease-specific measures for arthritis and musculoskeletal diseases.
17 now little of such plasticity in relation to musculoskeletal diseases.
18 articularly cardiovascular, respiratory, and musculoskeletal diseases.
19 n biotherapeutics are distinctly lacking for musculoskeletal diseases.
20 olumes were unintentional injuries (48 073), musculoskeletal diseases (38 030), and digestive disease
21 15.1%), chronic respiratory diseases (9.5%), musculoskeletal diseases (7.5%), and neurological and me
22                                              Musculoskeletal diseases affect up to 20% of adults worl
23 e function of HTRA1 in other closely related musculoskeletal diseases affecting bone and muscle remai
24             Osteoarthritis (OA) is a complex musculoskeletal disease and a leading cause of pain and
25 ns that cause debilitating acute and chronic musculoskeletal disease and are a significant public hea
26 CHIKV) cause large-scale epidemics of severe musculoskeletal disease and have been progressively expa
27 s disease systems; of the nondermatological, musculoskeletal disease and pain symptoms were prominent
28 at cause both debilitating acute and chronic musculoskeletal disease and potentially fatal encephalit
29            Osteoarthritis is the most common musculoskeletal disease and the leading cause of disabil
30 the greatest disparity in clinical trials of musculoskeletal disease and trauma (11.3% difference bet
31  Studies dealing with the economic burden of musculoskeletal diseases and the economic evaluation of
32 omorbidities (cardiovascular, metabolic, and musculoskeletal disease) and daily physical activity (by
33 docrine and related internal organ diseases, musculoskeletal diseases, and diseases of the circulator
34 ies except obstetric complications, skin and musculoskeletal diseases, and injuries and poisoning.
35  Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, and provides robust clinical e
36 flammation and tissue remodeling in numerous musculoskeletal diseases, and thus, we sought to determi
37                                              Musculoskeletal diseases are biomechanically complex and
38  clinical clues to identify nonrheumatologic musculoskeletal disease, as well as recent advances in o
39 th diagnostic or procedural codes suggesting musculoskeletal disease associated with C difficile diag
40 of mild clinical attenuation, with decreased musculoskeletal disease at early times after infection i
41 n IFN-beta-KO but not IRF7-KO mice mitigated musculoskeletal disease caused by CHIKV.
42                                              Musculoskeletal disease constitutes a wide variety of de
43                  Chronic pain and fatigue in musculoskeletal disease contribute significantly to disa
44                             Neurological and musculoskeletal diseases contributed the largest health
45                      Frequently evaluated in musculoskeletal disease, damage associated molecular pat
46 vascular disease, neurodegenerative disease, musculoskeletal disease, diabetes and cancer, obstacles
47 rk on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET).
48 t options for arthrofibrosis, a debilitating musculoskeletal disease, fail to treat the disease etiol
49 0 chapters (cardiovascular, respiratory, and musculoskeletal diseases) found to be robustly associate
50              The management of rheumatic and musculoskeletal diseases has transformed over two decade
51 Osteoarthritis (OA) is a common degenerative musculoskeletal disease highly prevalent in aging societ
52 s in patients with cutaneous, serositis, and musculoskeletal disease; however, the increase in CSF-1
53                        Many neurological and musculoskeletal diseases impair movement, which limits p
54  that cause debilitating, and often chronic, musculoskeletal disease in humans.
55 es that cause debilitating acute and chronic musculoskeletal disease in humans.
56 s that causes debilitating acute and chronic musculoskeletal disease in humans.
57 a virus that caused dramatically less severe musculoskeletal disease in mice.
58 otected against both CHIKV- and MAYV-induced musculoskeletal disease in mice.
59 es can be excellent tools for modeling human musculoskeletal diseases in a dish and for rapid drug sc
60 ristics of arthritis and other rheumatic and musculoskeletal diseases in this emerging US population.
61  the severity of both RRV- and CHIKV-induced musculoskeletal disease, including a reduction in inflam
62 anifestation of clinical symptoms in various musculoskeletal diseases, including muscular dystrophies
63 e is emerging to link age-associated complex musculoskeletal diseases, including osteoarthritis (OA),
64 studies of the biologic functions of MSCs in musculoskeletal diseases, including osteoporosis and ost
65 ditions requiring MRI studies for diagnosis (musculoskeletal diseases, infections, or cancer).
66                                              Musculoskeletal disease is prevalent in society and with
67                                 Degenerative musculoskeletal diseases like osteoarthritis can be init
68 linical manifestations, including arthritis, musculoskeletal disease, meningitis, encephalitis, and d
69 e infections, and children with PVL-positive musculoskeletal disease might have increased morbidity.
70  replicate in vivo development would benefit musculoskeletal disease modeling and regenerative medici
71  and jointly predicted back and degenerative musculoskeletal diseases (MSDs).
72                          Providers who treat musculoskeletal diseases need to become familiar with em
73 min D deficiency) was one of the most common musculoskeletal diseases of the paediatric population pr
74 g persons with chronic conditions other than musculoskeletal disease or with no chronic conditions.
75 olds (OR = 2.75, 95% CI 1.48-5.12), suffered Musculoskeletal diseases (OR = 1.61, 95% CI 1.02-2.56),
76 h an interval of 0.98 years between skin and musculoskeletal disease (P = 2.05 x 10(-6) ), compared w
77  Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases presents GRADE-assessed recomme
78 ics can predict outcomes like injury risk or musculoskeletal disease progression.
79 ctor 6 (CCN6) are linked to the debilitating musculoskeletal disease Progressive Pseudo Rheumatoid Dy
80 sed NCDs, except kidney diseases, cancer and musculoskeletal diseases related to work, with IRR rangi
81 l muscle-restricted CHIKV to show that while musculoskeletal disease requires viral replication in af
82 S, and the 19 novel findings include several musculoskeletal diseases, respiratory diseases, digestiv
83                           Most rheumatic and musculoskeletal diseases (RMDs) can be placed along a sp
84 es (RMR, 1.28; 95% CI, 1.21-1.34; P < .001), musculoskeletal diseases (RMR, 1.19; 95% CI, 1.04-1.36;
85 theless, mental illness, cardiovascular, and musculoskeletal diseases stand out as likely major cause
86                                      Chronic musculoskeletal diseases such as arthritis, malignancy,
87 pathic scoliosis (IS) is a common paediatric musculoskeletal disease that displays a strong female bi
88              Osteoarthritis (OA) is a common musculoskeletal disease that leads to deterioration of a
89 eed for alternative biological approaches to musculoskeletal disease therapy.
90 he combination of cardiovascular disease and musculoskeletal disease was the most prevalent (15% [n =
91 re, using mouse models of alphavirus-induced musculoskeletal disease, we demonstrate that NLRP3 inhib
92         Chikungunya can give rise to chronic musculoskeletal diseases, which can last for months to y
93 ct physicians treating patients with chronic musculoskeletal diseases, who may be reluctant to prescr
94 Psoriatic arthritis (PsA) is an inflammatory musculoskeletal disease with a chronic, progressive cour
95 ew opportunities for direct study of MSCs in musculoskeletal diseases without the requirement for cul